HAE
Haemonetics Corporation
Company Overview
| Mkt Cap | $2.43B | Price | $50.01 |
| Volume | 462.82K | Change | +0.04% |
| P/E Ratio | 14.5 | Open | $49.58 |
| Revenue | $1.4B | Prev Close | $49.99 |
| Net Income | $167.7M | 52W Range | $47.32 - $94.99 |
| Div Yield | N/A | Target | $78.00 |
| Overall | 58 | Value | 80 |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyHaemonetics Corporation (HAE) is a leading Healthcare company in the Medical Instruments & Supplies industry, currently trading at $50.01 with a market capitalization of $2.43 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows HAE with a volume of 463K shares. The stock opened down 0.82% from yesterday's close of $49.99. Current analyst estimates project earnings of $4.8 per share for this year, with next year targeting $5.35.
HAE demonstrates concerning technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including TMO, SYK, BDX, CERS, BAX.
Key investment considerations for HAE include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 56.0%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 2, 2025 at 10:59 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HAE | $50.01 | +0.0% | 462.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |